10X Genomics

10X Genomics

Building tools for scientific discovery that reveal and address the true complexities of biology and disease. Learn more

Financials

Estimates*

Edit
Revenues, earnings & profits over time
USD2020202120222023202420252026
Revenues299m490m516m619m647m717m789m
% growth22 %64 %5 %20 %5 %11 %10 %
EBITDA(82.5m)(53.5m)(161m)(205m)(138m)(89.2m)14.8m
% EBITDA margin(28 %)(11 %)(31 %)(33 %)(21 %)(12 %)2 %
Profit(543m)(58.2m)(166m)(255m)(159m)(109m)(47.6m)
% profit margin(182 %)(12 %)(32 %)(41 %)(25 %)(15 %)(6 %)
EV / revenue48.8x32.7x7.2x10.1x3.8x3.4x2.8x
EV / EBITDA-176.8x-300.0x-23.2x-30.4x-17.9x-27.0x151.7x
R&D budget123m212m266m331m---
R&D % of revenue41 %43 %51 %54 %---

Source: Dealroom estimates

  • Edit
DateInvestorsAmountRound
-

N/A

-
N/A

$3.0m

Series A
N/A

$22.4m

Series A

$55.5m

Series B

$55.0m

Series C

$50.0m

Series D

$75.0m

Debt
*

$35.0m

Valuation: $1.3b

8.9x EV/LTM Revenues

-12.3x EV/LTM EBITDA

Late VC
N/A

$390m

Valuation: $3.7b

25.3x EV/LTM Revenues

-34.9x EV/LTM EBITDA

IPO
*
N/A

N/A

Post IPO Equity
Total Funding€201m

Recent News about 10X Genomics

Edit
More about 10X Genomicsinfo icon
Edit

10x Genomics is a biotechnology company that focuses on advancing genomic research through innovative products and solutions. The company operates primarily in the life sciences sector, serving academic, clinical, and pharmaceutical researchers. Their main offerings include tools and technologies for single-cell analysis, spatial gene expression, and immune profiling. These tools help scientists understand complex biological systems by analyzing genetic information at a very detailed level.

The market 10x Genomics operates in is highly specialized and rapidly growing, driven by the increasing demand for personalized medicine and advanced research capabilities. Their clients are typically research institutions, universities, hospitals, and pharmaceutical companies that require high-resolution genomic data to drive their studies and develop new treatments.

10x Genomics' business model revolves around selling advanced laboratory equipment and consumables, such as reagents and microfluidic chips, which are essential for conducting genomic experiments. Additionally, they offer software solutions that help researchers analyze and interpret the vast amounts of data generated by their experiments. The company generates revenue through the sale of these products and services, as well as through ongoing support and training for their clients.

In summary, 10x Genomics is a key player in the genomic research field, providing cutting-edge tools and solutions that enable scientists to explore and understand the complexities of the human genome. Their focus on innovation and high-quality products has positioned them as a leader in this niche market.

Keywords: Genomics, Biotechnology, Single-cell analysis, Spatial gene expression, Immune profiling, Research tools, Life sciences, Personalized medicine, Data analysis, Laboratory equipment.

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.

Investments by 10X Genomics

Edit
EPINOMICS
ACQUISITION by 10X Genomics Aug 2018
ReadCoor
ACQUISITION by 10X Genomics Oct 2020
Spatial Transcriptomics
ACQUISITION by 10X Genomics Dec 2018
CARTANA
ACQUISITION by 10X Genomics Oct 2020